Skip to main content

Provider

By Nathan Eddy | 02:46 pm | May 03, 2024
The open-source gene editor is freely available to license for commercial use and ethical research.
By Jessica Hagen | 01:22 pm | May 03, 2024
The Agency alleges the company's CT and ultrasonography systems are noncompliant with good manufacturing requirements.
By Jessica Hagen | 03:11 pm | May 02, 2024
The company will use the funds to accelerate its AI capabilities and for strategic and commercial growth.
By Jessica Hagen | 01:00 pm | May 02, 2024
Dr. Julia Frydman will be the oncology-focused company's first medical director for palliative care. She will oversee its new Enhanced Supportive Care program.
By Jessica Hagen | 05:57 pm | May 01, 2024
The new platform for will offer video visits for rare disease diagnosis and longitudinal care.
By Susan Morse | 03:02 pm | May 01, 2024
Business model is unsustainable due to a challenging reimbursement environment and escalating operating costs, company says.
By Jessica Hagen | 02:51 pm | April 30, 2024
The wearable-tech company broadened its reach to 56 markets worldwide, added Italian and Latin American Spanish to its app and appointed three C-suite executives.
By Trevor Dermody | 01:43 pm | April 30, 2024
The consortium will allow Talkspace users with high-acuity needs to access specialty care providers via clinician referral or through Health Collective, its wellness ecosystem.
By Adam Ang | 05:36 am | April 30, 2024
It is envisioned to cover greater distances, serving Australia's rural and remote communities, while being sustainable.
By Adam Ang | 04:18 am | April 30, 2024
They had been designated as innovative medical devices.